Written by Richard Simmons| Monday, 22 August 2011| There is 1 comment
Pfizer, the manufacturer of the world's best selling erectile dysfunction medication has won an important legal victory in America which means that Teva Pharmaceuticals Industries will not be allowed to make generic versions of Viagra until the end of 2020. Pfizer who are determined to protect their patent rights until they expire have launched legal actions against a number of generic pharmaceutical manufacturers which they are confident of winning.

The main threat to Viagra and Pfizer however does not really come from the generic manufacturers who generally abide by the law, but from the hundreds of pharmaceutical companies in countries like China and India who operate outside of their country's legal guidelines and who export millions if not billions of pounds worth of fake Viagra, Cialis and Levitra all around the world.
In response to this Pfizer has whole departments set up which employ hundreds of people to track down and monitor the flow of counterfeit medication around world. They are not just dealing with petty criminals but huge and sophisticated criminal organizations which make huge profits despite the fact that the majority of their medications are substandard and even dangerous.
The World Health Organization has published figures which show that counterfeit medication manufacturers kill hundreds of thousands of people every year especially in developed countries. While it is true that not many people die from fake Viagra, fake Cialis and fake Levitra the profits from these impotence medications are huge and are used to fund not only the manufacturer of fake drugs such as cancer medications but also have been known to be channeled into a whole range of serious criminal activity and even terrorist organizations.
Using anything other than the approved medications for erectile dysfunction is not only likely to do yourself serious harm but could end up harming innocent people all over the world.

Thadeus said:
Fields marked with * are required.